Healthcare Sales & Marketing Network News: Nektar Therapeutics

Searching News Database: Nektar Therapeutics

HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Aug 2021
Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Oct 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Apr 2020
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 13 Jan 2020
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 1 Oct 2019
Nektar Announces Key Executive Promotions
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 May 2019
Nektar Announces the Launch of Inheris Biopharma, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2018
Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and �ric Lefebvre as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Nov 2017
Phase III study with Amikacin Inhale in intubated and mechanically ventilated patients with Gram-negative pneumonia does not meet primary endpoint of superiority
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 25 Aug 2017
Rigel Welcomes Brian Kotzin, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Oct 2016
Rigel Expands Leadership Team in Research and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Apr 2016
Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 19 Mar 2015
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
Biopharmaceuticals

HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
Devices Neurology Personnel

HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2013
Auspex Appoints Pratik Shah as CEO and Expands Executive Team
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 13 Jun 2013
Cubist Names Dr. Lorianne Masuoka Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2012
CytomX Therapeutics Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2011
TARIS Appoints Christopher Searcy as the Company�s Chief Business Officer
Biopharmaceuticals Urology Personnel

HSMN NewsFeed - 9 Feb 2011
Geron Appoints David Greenwood President, Interim CEO and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2010
TARIS Appoints Sarma Duddu as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2010
MicroCHIPS Taps Medical Industry Veteran as Next CEO
Devices Personnel

HSMN NewsFeed - 14 Dec 2009
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2009
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Mar 2009
Savara Expands Board of Directors, Appoints Three New Members
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 4 Feb 2009
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 29 Jan 2009
Nektar Announces Retirement of Irwin Lerner from Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Dec 2008
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 21 Oct 2008
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Aug 2008
Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2008
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2008
Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 May 2008
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2008
Auspex Pharmaceuticals Announces Series B Financing; Appointment of Ajit Gill as President and Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 23 Apr 2008
InSite Vision Appoints New Vice President of Operations
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 23 Apr 2008
FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest Milestone for Nektar's PEGylation Technology Platform
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 9 Apr 2008
Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
Biopharmaceuticals Endocrinology Oncology

HSMN NewsFeed - 9 Apr 2008
Pfizer Statement on Exubera Labeling Update in the United States
Biopharmaceuticals Endocrinology Oncology

HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Feb 2008
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2008
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2008
Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2007
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
Biopharmaceuticals

HSMN NewsFeed - 11 Dec 2007
Nektar Promotes John Nicholson to Serve as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2007
Pfizer and Nektar Reach Agreement on Exubera(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 18 Oct 2007
Nektar Therapeutics Issues Statement on Exubera
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 18 Sep 2007
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Aug 2007
Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2007
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 24 May 2007
Nektar Announces New Organizational Structure and Spending Reduction Initiatives to Solidify the Company's Leadership Position in PEGylation and Pulmonary Drug Development
Biopharmaceuticals

HSMN NewsFeed - 9 Apr 2007
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2007
Bio-Rad Announces the Appointment of New Board Member
Diagnostics Personnel

HSMN NewsFeed - 8 Jan 2007
Nektar Appoints Howard W. Robin President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2006
AGA Medical Appoints Brigid A. Makes Chief Financial Officer
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 18 Sep 2006
European Commission Grants Orphan Medicinal Product Designation to Nektar's Amphotericin B Inhalation Powder (ABIP) for the Prevention of Pulmonary Fungal Infections in Patients Deemed At Risk
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 14 Sep 2006
Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 7 Jul 2006
Nektar and University of Alabama in Huntsville Announce Agreement to Settle Litigation
Biopharmaceuticals Drug Delivery Litigation

HSMN NewsFeed - 22 May 2006
FDA Grants Fast Track Designation to Nektar's Amphotericin B Inhalation Powder (ABIP) for Prevention of Pulmonary Fungal Infections in At-Risk Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Mar 2006
Pfizer Completes Acquisition of Worldwide Rights to Exubera From sanofi-aventis
Biopharmaceuticals Endocrinology Acquisitions

HSMN NewsFeed - 14 Feb 2006
Nektar Announces That U.S. FDA Has Granted Orphan Drug Designation to the First Amphotericin B Inhalation Powder to Prevent Pulmonary Fungal Infections in Immunosuppressed Patients
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 27 Jan 2006
Pfizer Receives FDA Approval for Exubera, the First Inhalable Form of Insulin for Controlling Type 1 and Type 2 Diabetes in Adults
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 26 Jan 2006
European Commission Approves Exubera(R) (Inhaled Human Insulin) for Treatment of Type 1 and Type 2 Diabetes
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Jan 2006
Nektar Therapeutics Appoints New Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jan 2006
Pfizer to Acquire the sanofi-aventis Worldwide Rights to Exubera(R) (Inhaled Human Insulin)
Biopharmaceuticals Acquisitions

Return to NewsFeed

Additional items found! 30

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 30 additional stories matching:
Nektar Therapeutics
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.